Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancerGiannis Mountzios, Petros Christopoulos, Helena Linardou et al.|ESMO Open|2021Cited by 93
Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancerElena Fountzilas, George Fountzilas, Mattheos Bobos et al.|ESMO Open|2019Cited by 50
A study of gene expression markers for predictive significance for bevacizumab benefit in patients with metastatic colon cancer: a translational research study of the Hellenic Cooperative Oncology Group (HeCOG)George Pentheroudakis, George Fountzilas, Vassiliki Kotoula et al.|BMC Cancer|2014Cited by 35